Literature DB >> 29959025

Characterization of 108 Genomic DNA Reference Materials for 11 Human Leukocyte Antigen Loci: A GeT-RM Collaborative Project.

Maria P Bettinotti1, Deborah Ferriola2, Jamie L Duke2, Timothy L Mosbruger2, Nikolaos Tairis2, Lawrence Jennings3, Lisa V Kalman4, Dimitri Monos5.   

Abstract

The highly polymorphic human leukocyte antigen (HLA) genes, located in the human major histocompatibility complex, encode the class I and II antigen-presenting molecules, which are centrally involved in the immune response. HLA typing is used for several clinical applications, such as transplantation, pharmacogenetics, and diagnosis of autoimmune disease. HLA typing is highly complex because of the homology of HLA genes and pseudogenes and the extensive polymorphism in the population. The Centers for Disease Control and Prevention established the Genetic Testing Reference Materials Coordination Program (GeT-RM) in partnership with the genetics community to improve the availability of genomic DNA reference materials necessary for quality assurance of genetic laboratory testing. The GeT-RM together with three clinical laboratories and the Coriell Cell Repositories have characterized genomic DNA obtained from a panel of 108 cell lines for all HLA classic polymorphic loci: HLA-A, B, C, DRB1, DRB3, DRB4, DRB5, DQA1, DQB1, DPA1, and DPB1. The goal was to develop a publicly available and renewable source of well-characterized genomic DNA reference materials to support molecular HLA typing assay development, validation, and verification, quality control, and proficiency testing. These genomic DNA samples are publicly available from the National Institutes of General Medical Science Repository at the Coriell Cell Repositories.
Copyright © 2018 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29959025      PMCID: PMC6939753          DOI: 10.1016/j.jmoldx.2018.05.009

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  27 in total

Review 1.  Association for Molecular Pathology statement. Recommendations for in-house development and operation of molecular diagnostic tests.

Authors: 
Journal:  Am J Clin Pathol       Date:  1999-04       Impact factor: 2.493

2.  Determining performance characteristics of an NGS-based HLA typing method for clinical applications.

Authors:  J L Duke; C Lind; K Mackiewicz; D Ferriola; A Papazoglou; A Gasiewski; S Heron; A Huynh; L McLaughlin; M Rogers; L Slavich; R Walker; D S Monos
Journal:  HLA       Date:  2016-02-16       Impact factor: 4.513

Review 3.  Missing or altered self: human NK cell receptors that recognize HLA-C.

Authors:  Hugo G Hilton; Peter Parham
Journal:  Immunogenetics       Date:  2017-07-10       Impact factor: 2.846

4.  Recommendations for donor human leukocyte antigen assessment and matching for allogeneic stem cell transplantation: consensus opinion of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN).

Authors:  C Alan Howard; Marcelo A Fernandez-Vina; Frederick R Appelbaum; Dennis L Confer; Steven M Devine; Mary M Horowitz; Adam Mendizabal; Ginna G Laport; Marcelo C Pasquini; Stephen R Spellman
Journal:  Biol Blood Marrow Transplant       Date:  2014-09-30       Impact factor: 5.742

Review 5.  T cell-mediated hypersensitivity reactions to drugs.

Authors:  Rebecca Pavlos; Simon Mallal; David Ostrov; Soren Buus; Imir Metushi; Bjoern Peters; Elizabeth Phillips
Journal:  Annu Rev Med       Date:  2014-10-27       Impact factor: 13.739

6.  Human NK cell education by inhibitory receptors for MHC class I.

Authors:  Nicolas Anfossi; Pascale André; Sophie Guia; Christine S Falk; Sophie Roetynck; C Andrew Stewart; Violette Breso; Coralie Frassati; Denis Reviron; Derek Middleton; François Romagné; Sophie Ugolini; Eric Vivier
Journal:  Immunity       Date:  2006-08-10       Impact factor: 31.745

Review 7.  Narcolepsy with cataplexy.

Authors:  Yves Dauvilliers; Isabelle Arnulf; Emmanuel Mignot
Journal:  Lancet       Date:  2007-02-10       Impact factor: 79.321

8.  High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.

Authors:  Stephanie J Lee; John Klein; Michael Haagenson; Lee Ann Baxter-Lowe; Dennis L Confer; Mary Eapen; Marcelo Fernandez-Vina; Neal Flomenberg; Mary Horowitz; Carolyn K Hurley; Harriet Noreen; Machteld Oudshoorn; Effie Petersdorf; Michelle Setterholm; Stephen Spellman; Daniel Weisdorf; Thomas M Williams; Claudio Anasetti
Journal:  Blood       Date:  2007-09-04       Impact factor: 22.113

Review 9.  An overview of HLA typing for hematopoietic stem cell transplantation.

Authors:  Katy Latham; Ann-Margaret Little; J Alejandro Madrigal
Journal:  Methods Mol Biol       Date:  2014

Review 10.  Celiac disease: Autoimmunity in response to food antigen.

Authors:  J Stamnaes; L M Sollid
Journal:  Semin Immunol       Date:  2015-11-18       Impact factor: 11.130

View more
  2 in total

1.  Behçet's disease risk-variant HLA-B51/ERAP1-Hap10 alters human CD8 T cell immunity.

Authors:  Ann Cavers; Matthias Christian Kugler; Yesim Ozguler; Arshed Fahad Al-Obeidi; Gulen Hatemi; Beatrix M Ueberheide; Didar Ucar; Olivier Manches; Johannes Nowatzky
Journal:  Ann Rheum Dis       Date:  2022-08-03       Impact factor: 27.973

2.  Technical Performance of a 430-Gene Preventative Genomics Assay to Identify Multiple Variant Types Associated with Adult-Onset Monogenic Conditions, Susceptibility Loci, and Pharmacogenetic Insights.

Authors:  Ari Silver; Gabriel A Lazarin; Maxwell Silver; Meghan Miller; Michael Jansen; Christine Wechsberg; Erin Dekanek; Stav Grossfeld; Tim Herpel; Dinura Gunatilake; Alexander Bisignano; Malgorzata Jaremko
Journal:  J Pers Med       Date:  2022-04-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.